Company Overview of Genome Corp.
Genome Corp. engages in developing and commercializing the DNA sequencing technology. It offers proprietary technologies, massively-parallel sanger sequencing, for sequencing and analyzing the genomes of individuals. The company serves researchers and clinicians. Genome Corp. was founded in 2007 and is based in Providence, Rhode Island.
2800 Financial Plaza
Providence, RI 02903
Founded in 2007
Key Executives for Genome Corp.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Genome Corp., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.